SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 406 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,775,340 | +6.7% | 138,388 | +0.8% | 0.01% | +7.7% |
| Q2 2023 | $15,716,757 | -5.2% | 137,240 | +14.1% | 0.01% | -13.3% |
| Q1 2023 | $16,575,574 | -39.6% | 120,261 | -60.5% | 0.02% | -11.8% |
| Q4 2021 | $27,441,000 | +444.8% | 304,735 | +459.5% | 0.02% | +466.7% |
| Q3 2021 | $5,037,000 | +4.3% | 54,461 | -12.3% | 0.00% | 0.0% |
| Q2 2021 | $4,830,000 | +4.3% | 62,129 | -0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,631,000 | -98.9% | 62,133 | -97.5% | 0.00% | -99.0% |
| Q4 2020 | $424,501,000 | +16.0% | 2,489,892 | -4.4% | 0.30% | +3.1% |
| Q3 2020 | $365,830,000 | +290.7% | 2,605,072 | +346.1% | 0.29% | +245.9% |
| Q2 2020 | $93,636,000 | +23.4% | 583,981 | -24.7% | 0.08% | -7.6% |
| Q1 2020 | $75,900,000 | -23.6% | 775,920 | +0.8% | 0.09% | -8.0% |
| Q4 2019 | $99,362,000 | +20.0% | 770,011 | -30.0% | 0.10% | +14.9% |
| Q3 2019 | $82,829,000 | -45.5% | 1,099,693 | +9.9% | 0.09% | -42.4% |
| Q2 2019 | $151,995,000 | +26.6% | 1,000,299 | -0.7% | 0.15% | +26.9% |
| Q1 2019 | $120,081,000 | +7.6% | 1,007,479 | -1.5% | 0.12% | -4.8% |
| Q4 2018 | $111,587,000 | -43.3% | 1,022,515 | -16.2% | 0.12% | -30.9% |
| Q3 2018 | $196,962,000 | +22.8% | 1,219,503 | +0.5% | 0.18% | +16.0% |
| Q2 2018 | $160,453,000 | +63.2% | 1,213,899 | -8.5% | 0.16% | +59.2% |
| Q1 2018 | $98,318,000 | +53.6% | 1,327,003 | +15.4% | 0.10% | +55.6% |
| Q4 2017 | $63,998,000 | +23.3% | 1,150,210 | +0.6% | 0.06% | +18.9% |
| Q3 2017 | $51,885,000 | +174.4% | 1,143,853 | +103.9% | 0.05% | +165.0% |
| Q2 2017 | $18,910,000 | +13.4% | 560,959 | -0.4% | 0.02% | +11.1% |
| Q1 2017 | $16,675,000 | +7.9% | 563,333 | 0.0% | 0.02% | +5.9% |
| Q4 2016 | $15,452,000 | -81.9% | 563,333 | -59.6% | 0.02% | -81.5% |
| Q3 2016 | $85,593,000 | +233.8% | 1,393,788 | +3.7% | 0.09% | +228.6% |
| Q2 2016 | $25,641,000 | -20.7% | 1,344,558 | +60.3% | 0.03% | -12.5% |
| Q4 2015 | $32,354,000 | +577.1% | 838,629 | +463.6% | 0.03% | +540.0% |
| Q3 2015 | $4,778,000 | -55.5% | 148,798 | -57.8% | 0.01% | -50.0% |
| Q2 2015 | $10,742,000 | -50.3% | 353,000 | -65.5% | 0.01% | -50.0% |
| Q3 2014 | $21,603,000 | – | 1,023,834 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |